Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
FDA approves Zepbound, a new obesity drug that will take on …
Nov 8, 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.
F.D.A. Approves New Obesity Drug That Will Compete With …
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy.
FDA approves Zepbound® (tirzepatide) as the first and only …
INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound ® (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. 1 Zepbound may help adults with moderate-to-severe ...
Powerful new obesity drug poised to upend weight loss care
Apr 27, 2023 · Drugmaker Eli Lilly reported Thursday that tirzepatide helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial. For those without the disease, the drug has …
Questions and answers about the new anti-obesity medications
Jan 1, 2024 · A blockbuster batch of anti-obesity drugs continues to grab headlines and dominate social media posts, and not just because the new year revs up our resolve to shed pounds. The medications — semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) — are backed by science and stunning accounts of people losing as much as 20% ...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
On Sunday, Lilly released new data about retatrutide, an injectable drug that combines GLP-1 and glucagon, plus another hormone called GIP. GIP is thought to improve how the body breaks down...
New Obesity Drug MariTide Helps Patients Lose Up to 20% of …
Nov 26, 2024 · The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year.
F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea - The New …
Dec 20, 2024 · The drug’s maker, Eli Lilly, announced that the agency authorized Zepbound for people with obesity and moderate to severe obstructive sleep apnea. Millions of Americans have the condition, and ...
New obesity drug tirzepatide poised to upend weight loss care - CBS News
Apr 28, 2023 · Tirzepatide, an Eli Lilly and Co. drug approved to treat Type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity lose up to 16% of their...
- Some results have been removed